INIS
applications
18%
carriers
30%
children
51%
decision making
17%
diseases
15%
dna
16%
embryos
39%
ethics
51%
exploration
16%
fertility
12%
fetuses
16%
gametes
16%
genetics
77%
humans
51%
information
13%
medicine
16%
mitochondria
14%
netherlands
14%
patients
33%
policy
14%
populations
13%
recommendations
14%
reflection
12%
reproduction
41%
risks
28%
safety
13%
screening
100%
stem cells
16%
testing
63%
women
25%
Keyphrases
Assisted Reproductive Technology
30%
Carrier Screening
18%
Clinical Application
17%
Down Syndrome
11%
Dutch
18%
Embryonic Structures
13%
ESHRE
11%
Ethical Issues
43%
Ethical Reflection
12%
Ethics
46%
European Society
12%
European Society of Human Genetics
18%
Expanded Carrier Screening
21%
Fetus
17%
Future Child
18%
Genetic Screening
11%
Human Embryo
12%
Human Embryology
17%
Human Reproduction
13%
Informed Consent
11%
Law
11%
Medically Assisted Reproduction
24%
Netherlands
17%
Noninvasive Prenatal Testing
18%
Pregnant Women
15%
Preimplantation Genetic Diagnosis
34%
Prenatal Screening
35%
Reproductive Decision-making
15%
Responsible Innovation
12%
Unsolicited Findings
14%
Medicine and Dentistry
Assisted Reproduction
36%
Assisted Reproductive Technology
15%
Clinical Research
7%
Decision Making
11%
Disease
27%
Diseases
26%
Down Syndrome
13%
Exome Sequencing
11%
Family History
7%
Fetal Disease
7%
Fetal Therapy
7%
Genetic Disorder
11%
Genetic Screening
30%
Genome Sequencing
6%
Germ Cell
9%
Health Care
6%
Human Embryo
14%
Human Genetics
21%
In Vitro
9%
Informed Consent
14%
Medicine
13%
Nuclear Transfer
6%
Offspring
9%
Oocyte
9%
Pediatrics
8%
Preimplantation Genetic Diagnosis
8%
Prenatal Screening
32%
Reproductive Medicine
24%
Reproductive Technology
6%
Stem Cell
15%